« Back
Home /
EBV BALF-4 276-284 (HLA-A*02:01)

EBV BALF-4 276-284 (HLA-A*02:01)

Item no.	EP11237_5
Manufacturer	peptides & elephants
Amount	5 mg
Quantity options	1 mg 5 mg
Category	Peptides & Proteins Peptides
Type	Peptides
Applications	FC
Specific against	other
Purity	0,95
Sequence	FLDKGTYTL
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	FLDKGTYTL Envelope glycoprotein B HLA-A*02:01 Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma Flow Cytometry
Available
Manufacturer - Category	Peptides
Shipping Temperature	freeze dried
Storage Conditions	Store dry at -20°C
C-Terminus	OH
N-Terminus	H
Counter-Ion	TFA
Description	FLDKGTYTL is a linear peptidic epitope (epitope ID16548) studied as part of Envelope glycoprotein B from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide EBV BALF-4 276–284 (HLA-A*02:01) FLDKGTYTL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Gene	BALF4
Indication	Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma
Protein	Envelope glycoprotein B
Allele	HLA-A*02:01
Remarks	sterile and endotoxin free

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 11/6/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer